Cas:3385-94-2 bis(trimethylsilyl) sulfide manufacturer & supplier

We serve Chemical Name:bis(trimethylsilyl) sulfide CAS:3385-94-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

bis(trimethylsilyl) sulfide

Chemical Name:bis(trimethylsilyl) sulfide
CAS.NO:3385-94-2
Synonyms:Disilathiane,hexamethyl;Bis(trimethylsilyl) Sulfide;Disilthiane,hexamethyl;1,1,1,3,3,3-Hexamethyldisilathiane;EINECS 222-201-4;Thiobis(trimethylsilane);Hexamethyldisilthiane;Bis(trimethylsilyl)sulfide;Hexamethyldisilathiane;trimethylsilyl sulfide;MFCD00014851
Molecular Formula:C6H18SSi2
Molecular Weight:178.44300
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:164 °C(lit.)
Density:0.846 g/mL at 25 °C(lit.)
Index of Refraction:n20/D 1.4586(lit.)
PSA:25.30000
Exact Mass:178.06700
LogP:3.38940

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993 3/PG 3
Packing Group:II


Contact us for information like Disilathiane,hexamethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00014851 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Hexamethyldisilthiane Use and application,Thiobis(trimethylsilane) technical grade,usp/ep/jp grade.


Related News: So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. ethyl 6,7-dimethoxy-1-(3-((2-methyl-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl)oxy)benzoyl)isoquinoline-4-carboxylate manufacturers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 11-bromo-1,5-dioxaspiro[5.5]undecane suppliers AZ’s chief financial officer and incoming Alexion head Marc Dunoyer acknowledged that the reimbursement infrastructure for rare disease drugs in China isn’t as advanced as it is in many developed economies. The rare disease market in China is still small, but there’s a growing recognition of its importance from authorities, he added. 2-((1R,2S,3S,4S)-3-Bromo-bicyclo[2.2.1]hept-2-ylselanyl)-pyridine vendor & factory.